4.6 Review

The role played by alternative splicing in antigenic variability in human endo-parasites

Journal

PARASITES & VECTORS
Volume 7, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1756-3305-7-53

Keywords

Plasmodium; Schistosoma; Trypanosoma; HIV; Alternate splicing; Immune evasion

Ask authors/readers for more resources

Endo-parasites that affect humans include Plasmodium, the causative agent of malaria, which remains one of the leading causes of death in human beings. Despite decades of research, vaccines to this and other endo-parasites remain elusive. This is in part due to the hyper-variability of the parasites surface proteins. Generally these surface proteins are encoded by a large family of genes, with only one being dominantly expressed at certain life stages. Another layer of complexity can be introduced through the alternative splicing of these surface proteins. The resulting isoforms may differ from each other with regard to cell localisation, substrate affinities and functions. They may even differ in structure to the extent that they are no longer recognised by the host's immune system. In many cases this leads to changes in the N terminus of these proteins. The geographical localisation of endo-parasitic infections around the tropics and the highest incidences of HIV-1 infection in the same areas, adds a further layer of complexity as parasitic infections affect the host immune system resulting in higher HIV infection rates, faster disease progression, and an increase in the severity of infections and complications in HIV diagnosis. This review discusses some examples of parasite surface proteins that are alternatively spliced in trypanosomes, Plasmodium and the parasitic worm Schistosoma as well as what role alternate splicing may play in the interaction between HIV and these endo-parasites.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities

Rahaba Marima, Rodney Hull, Mandisa Mbeje, Thulo Molefi, Kgomotso Mathabe, Abdulrahman M. Elbagory, Demetra Demetriou, Zodwa Dlamini

Summary: Precision oncology in the African population faces challenges due to the lack of genetic reference information from the African genome. Non-coding RNAs play an important role in the molecular pathways of tumorigenesis. Sub-Saharan Africa has high incidence and mortality rates of endometrial and prostate cancers.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Oncology

Unraveling the Complex Interconnection between Specific Inflammatory Signaling Pathways and Mechanisms Involved in HIV-Associated Colorectal Oncogenesis

Botle Precious Damane, Thanyani Victor Mulaudzi, Sayed Shakeel Kader, Pragalathan Naidoo, Suzana D. D. Savkovic, Zodwa Dlamini, Zilungile Lynette Mkhize-Kwitshana

Summary: The progress in HIV treatment has resulted in longer life expectancy, but people living with HIV are more prone to developing colorectal cancers due to chronic inflammation. Infections, especially parasitic infections, increase the risk of cancer and contribute to chronic inflammation, thereby promoting oncogenesis.

CANCERS (2023)

Article Oncology

The integrative bioinformatics approaches to predict the xanthohumol as anti-breast cancer molecule: Targeting cancer cells signaling PI3K and AKT kinase pathway

Kartikey Kumar Gupta, Kamal Kant Sharma, Harish Chandra, Himalaya Panwar, Nitin Bhardwaj, Najla A. Altwaijry, Aisha A. Alsfouk, Zodwa Dlamini, Obaid Afzal, Abdulmalik S. A. Altamimi, Shahanavaj Khan, Abhay Prakash Mishra

Summary: Xanthohumol has demonstrated significant binding affinity to multiple targets within breast cancer-related signaling pathways in in silico analysis, offering new research possibilities for breast cancer treatment.

FRONTIERS IN ONCOLOGY (2022)

Review Oncology

Genomic Interplay between Neoneurogenesis and Neoangiogenesis in Carcinogenesis: Therapeutic Interventions

Zodwa Dlamini, Richard Khanyile, Thulo Molefi, Botle Precious Damane, David Owen Bates, Rodney Hull

Summary: This review discusses how the processes of angiogenesis and neurogenesis are involved in cancer progression and are associated with poorer patient survival. These processes share signaling pathways and are often initiated together. Both processes require tissue changes and cell migration. They contribute to cancer progression by supplying nutrients and facilitating communication within the tumor. Additionally, they provide routes for cancer cells to migrate from the initial site to other areas of the body, leading to metastasis. The interplay between these processes in cancer development suggests the potential for targeted therapies.

CANCERS (2023)

Review Plant Sciences

Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward

Mohammed Alaouna, Clement Penny, Rodney Hull, Thulo Molefi, Nkhensani Chauke-Malinga, Richard Khanyile, Malose Makgoka, Meshack Bida, Zodwa Dlamini

Summary: Triple negative breast cancer (TNBC) is an aggressive subtype that lacks certain receptors. Phytochemicals, such as curcumin, resveratrol, and EGCG, show promise in inhibiting TNBC pathways. However, their limited bioavailability and lack of clinical evidence pose challenges for their use as single therapies. More research is needed to understand the role of phytochemicals in TNBC therapy and develop effective delivery mechanisms. This review discusses the potential of phytochemicals as a treatment option for TNBC.

PLANTS-BASEL (2023)

Review Plant Sciences

Reports of Plant-Derived Nanoparticles for Prostate Cancer Therapy

Abdulrahman M. Elbagory, Rodney Hull, Mervin Meyer, Zodwa Dlamini

Summary: Plants have potential as a source of phytomedicines with chemopreventive properties against prostate cancer. However, their incorporation as anticancer agents has been hindered by poor bioavailability. The use of phytochemicals as nanoparticles can overcome this issue and improve biocompatibility. Furthermore, phytochemicals can serve as targeting agents for tumor sites.

PLANTS-BASEL (2023)

Review Biochemistry & Molecular Biology

Multi-Omics and Management of Follicular Carcinoma of the Thyroid

Thifhelimbilu Emmanuel Luvhengo, Ifongo Bombil, Arian Mokhtari, Maeyane Stephens Moeng, Demetra Demetriou, Claire Sanders, Zodwa Dlamini

Summary: Follicular thyroid carcinoma (FTC) is a common and aggressive type of thyroid cancer that requires thorough histopathological analysis for accurate diagnosis and identification of aggressive markers. While small tumors can be treated with thyroid lobectomy, larger tumors and those with aggressive mutations require more comprehensive management strategies. The application of multi-omics approaches plays a significant role in the diagnosis and treatment of FTC.

BIOMEDICINES (2023)

Review Biochemistry & Molecular Biology

Immunomodulatory Gene-Splicing Dysregulation in Tumorigenesis: Unmasking the Complexity

Lorraine Tshegofatso Maebele, Thanyani Victor Mulaudzi, Madhavan Yasasve, Zodwa Dlamini, Botle Precious Damane

Summary: Cancer is a global health concern characterized by increasing incidence, morbidity, and mortality. The interaction between tumor and immune cells in the tumor microenvironment is facilitated by immunomodulatory proteins. Alternative splicing, regulated by splicing factors, produces multiple immunomodulatory proteins with varying functions from a single mRNA transcript. Dysregulation of alternative splicing contributes to tumorigenesis and cancer progression by generating abnormal mRNA transcripts encoding isoforms with altered functions. This review highlights the significance of understanding immunomodulatory gene splicing dysregulation in cancer and suggests utilizing specific immunomodulatory splicing isoforms to enhance current immunotherapies or develop novel cancer treatments.

MOLECULES (2023)

Review Oncology

Dissecting Microbiome-Derived SCFAs in Prostate Cancer: Analyzing Gut Microbiota, Racial Disparities, and Epigenetic Mechanisms

Thabiso Victor Miya, Rahaba Marima, Botle Precious Damane, Elisa Marie Ledet, Zodwa Dlamini

Summary: Prostate cancer is the most diagnosed cancer and the second leading cause of death in men worldwide. The human microbiome and its metabolites have been found to play a significant role in carcinogenesis and affect the efficacy of anticancer treatments. Short-chain fatty acids (SCFAs), a type of metabolite, have been shown to have a profound impact on the progression of prostate cancer.

CANCERS (2023)

Review Oncology

Alternative Splicing Events and Their Clinical Significance in Colorectal Cancer: Targeted Therapeutic Opportunities

Mosebo Armstrong Manabile, Rodney Hull, Richard Khanyile, Thulo Molefi, Botle Precious Damane, Nigel Patrick Mongan, David Owen Bates, Zodwa Dlamini

Summary: Colorectal cancer is a leading cause of cancer-related deaths globally, with increasing incidence in developing countries. Dysregulated alternative splicing processes in colorectal cancer can promote its development and progression by producing proteins that activate cancer-promoting genes or deactivate cancer-inhibiting genes. It is important to identify these dysregulated alternative splicing genes in order to develop targeted treatments and diagnostics to stop cancer development and progression.

CANCERS (2023)

Editorial Material Oncology

From Incidence to Intervention: A Comprehensive Look at Breast Cancer in South Africa

Zodwa Dlamini, Thulo Molefi, Richard Khanyile, Mahlori Mkhabele, Botle Damane, Alexandre Kokoua, Meshack Bida, Kamal S. Saini, Nkhensani Chauke-Malinga, Thifhelimbilu Emmanuel Luvhengo, Rodney Hull

Summary: Breast cancer in South Africa is facing significant challenges in terms of disparities in screening, treatment, and survival along ethnic and socioeconomic lines. Ethnic disparities exacerbate the issue, leading to delayed diagnosis among Black patients and highlighting healthcare inequities. Tackling these disparities requires a multifaceted strategy, including robust screening efforts, expedited treatment initiation, and tailored interventions for HIV-related complexities.

ONCOLOGY AND THERAPY (2023)

Article Oncology

Drug Standardization through Pharmacognostic Approaches and Estimation of Anticancer Potential of Chamomile (Matricaria chamomilla L.) using Prostate-Cancer cell lines: An In-vitro Study

Nida Khan, Mohd Afsahul Kalam, Mohd Tauseef Alam, Syed Anam Ul Haq, Wasia Showket, Zahoor A. Dar, Nida Rafiq, Waseem Mushtaq, Towseef Amin Rafeeqi, Mohammad Yunis Dar, Seema Akbar, Tariq Ahmad Butt, Riehana Gani, Uzma Majeed, Anis Ahmad Chaudhary, Hassan Ahmed Rudayni, Mohammed Al-Zharani, Sireen Abdul Rahim Shilbayeh, Ammena Yahia Binsaleh, Azza A. K. El-Sheikh, Zodwa Dlamini, Shabir Hussain Wani, Shahanavaj Khan, Khalid Z. Masoodi

Summary: Cancer, especially adenocarcinoma of prostate, is a major challenge globally. Medicinal plants, such as Matricaria chamomilla, are commonly used for cancer treatment. This study evaluated the pharmacognostic parameters of M. chamomilla and analyzed its antioxidant and cytotoxic activities. The results showed that M. chamomilla extracts met the drug standardization parameters and exhibited good antioxidant and anticancer activities. The ethyl acetate extract showed the highest anticancer activity, followed by aqueous, hydroalcoholic, petroleum benzene, and methanol extracts. The wound healing assay also demonstrated the significant effect of the ethyl acetate extract on prostate cancer cells.

JOURNAL OF CANCER (2023)

Review Endocrinology & Metabolism

Targeting Stem Cells in the Colorectal Cancer Microenvironment to Avert Drug Resistance in Pursuit of Novel Oncotherapies

Botle Precious Damane, Rahaba Marima, Thanyani Victor Mulaudzi, Zodwa Dlamini

Summary: Several studies have shown a higher incidence of colorectal cancer (CRC) in young black men, with most of them already having metastatic CRC. Cancer stem cells (CSCs) play a key role in CRC metastasis and drug resistance by continuously dividing into different phenotypes. Changes in the tumor microenvironment (TME) further contribute to cancer development, relapse, and therapeutic resistance. Targeting different CSC phenotypes may help in combating CRC.

JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS (2023)

Article Biochemistry & Molecular Biology

In Silico Bioinformatics Analysis on the Role of Long Non-Coding RNAs as Drivers and Gatekeepers of Androgen-Independent Prostate Cancer Using LNCaP and PC-3 Cells

Mandisa Mbeje, Jeyalakshmi Kandhavelu, Clement Penny, Mmamoletla Kgoebane-Maseko, Zodwa Dlamini, Rahaba Marima

Summary: This study aimed to compare the aberrantly expressed long non-coding RNAs (lncRNAs) in androgen-dependent and androgen-independent prostate cancer cells. Using a panel of PCa lncRNA genes and bioinformatics analysis, it was found that certain lncRNAs are involved in oncogenic pathways and interact with miRNAs, promoting the progression of prostate cancer. Understanding the interaction between lncRNAs and miRNAs may help in the identification of novel prognostic biomarkers and therapeutic targets for prostate cancer.

CURRENT ISSUES IN MOLECULAR BIOLOGY (2023)

Meeting Abstract Oncology

Identification of anti-neoplastic compounds on a triple negative breast cancer cell line from T. violacea

Zodwa Dlamini, Clement Penny, Rodney Hull, Mohammed Alouna

CANCER RESEARCH (2022)

No Data Available